Fingerprint
Dive into the research topics of 'Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses
Anna Morena D’Alise*, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martin-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review